Stocks
AnaptysBio (ANAB) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -0.71 | -10.00 | -7.65 | -4.29 | -1.42 | -0.43 | ||
| Changes by years, y/y, % | -96% | +1 316% | -23% | -44% | -67% | -40.6% | |||
AnaptysBio. EV/EBITDA
AnaptysBio. EV/EBITDA, changes, %
AnaptysBio (ANAB) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -0.63 | -1.37 | -4.09 | -5.06 | -4.41 | -0.43 | |
| Changes by years, y/y, % | -75% | -69% | +140% | +379% | +596% | |||
| Changes by quarters, q/q, % | -40% | +115% | +200% | +24% | -13% | |||
